Stada Arzneimittel AG’s private equity owners are resuming preparations for a listing of the German drugmaker after talks stalled on a potential sale to CapVest Partners, people with knowledge of the matter said.
Bain Capital and Cinven, which jointly own Stada, have started gearing up to hold an initial public offering of the business as soon as October, the people said. London-based buyout firm CapVest was in discussions to acquire Stada but it’s been unable to reach an agreement, according to the people, who asked not to be identified because the information is private.
CapVest was in ...
